- Home
- GIFT vs CALC Comparison
GIFT vs CALC Comparison
Compare GIFT & CALC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GIFT
- CALC
- Stock Information
- Founded
- GIFT 1999
- CALC 2011
- Country
- GIFT United States
- CALC United States
- Employees
- GIFT N/A
- CALC N/A
- Industry
- GIFT Catalog/Specialty Distribution
- CALC Biotechnology: Pharmaceutical Preparations
- Sector
- GIFT Consumer Discretionary
- CALC Health Care
- Exchange
- GIFT Nasdaq
- CALC Nasdaq
- Market Cap
- GIFT 50.0M
- CALC 44.7M
- IPO Year
- GIFT N/A
- CALC N/A
- Fundamental
- Price
- GIFT $1.42
- CALC $3.90
- Analyst Decision
- GIFT
- CALC Strong Buy
- Analyst Count
- GIFT 0
- CALC 4
- Target Price
- GIFT N/A
- CALC $20.50
- AVG Volume (30 Days)
- GIFT 61.1K
- CALC 23.9K
- Earning Date
- GIFT 11-15-2024
- CALC 11-07-2024
- Dividend Yield
- GIFT N/A
- CALC N/A
- EPS Growth
- GIFT N/A
- CALC N/A
- EPS
- GIFT N/A
- CALC N/A
- Revenue
- GIFT $83,435,815.00
- CALC N/A
- Revenue This Year
- GIFT N/A
- CALC N/A
- Revenue Next Year
- GIFT N/A
- CALC N/A
- P/E Ratio
- GIFT N/A
- CALC N/A
- Revenue Growth
- GIFT N/A
- CALC N/A
- 52 Week Low
- GIFT $0.50
- CALC $1.75
- 52 Week High
- GIFT $4.65
- CALC $8.38
- Technical
- Relative Strength Index (RSI)
- GIFT N/A
- CALC 41.63
- Support Level
- GIFT N/A
- CALC $4.05
- Resistance Level
- GIFT N/A
- CALC $4.29
- Average True Range (ATR)
- GIFT 0.00
- CALC 0.33
- MACD
- GIFT 0.00
- CALC -0.05
- Stochastic Oscillator
- GIFT 0.00
- CALC 10.17
About GIFT RDE Inc. Common Stock
RDE Inc through its wholly-owned subsidiary, has been in the business of connecting digital consumers, businesses and communities with dining and merchant deal options throughout the United States. The company connects digital consumers, businesses, and communities offering dining and merchant deal options nationwide restaurants, and retailers to customers. The Company buys merchant gift cards from the general public and distributors at a discount and then resells them at a markup. The Company also derives revenue from the sale of discount certificates for restaurants on behalf of third-party restaurants.
About CALC CalciMedica Inc.
CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapies for life-threatening inflammatory diseases with high unmet need. Its proprietary technology targets the inhibition of calcium release-activated calcium channels designed to modulate the immune response and protect against tissue cell injury, with the potential to provide therapeutic benefits in life-threatening inflammatory diseases for which there are no approved therapies.